A new target for neuroblastoma

Neuroblastoma, a cancer that starts in nerve tissue outside of the brain, is the third most common cancer in children and accounts for about 15 percent of pediatric cancer-related deaths.

Sirtuins (SIRTs), a family of proteins with roles in metabolism, aging and genomic stability, have been linked to various cancers, but their role in neuroblastoma has not been explored.

Dai Chung, MD, and colleagues found that a non-specific SIRT inhibitor reduced the growth rate of cultured neuroblastoma cells and induced the formation of neurite-like structures consistent with (maturation). Using a genetic strategy to knock down specific SIRTs, they discovered that SIRT6 promotes neuroblastoma cell growth and represses differentiation. SIRT6 expression was reduced in differentiated human neuroblastoma samples and in cultured neuroblastoma cells that were induced to differentiate using retinoic acid.

The findings, reported in the February issue of Anticancer Research, highlight the oncogenic properties of SIRT6 in neuroblastoma and suggest SIRT6 as a target for new therapeutics for .


Explore further

Oestrogen causes neuroblastoma cells to mature into neurons

More information: Inhibition of Sirtuin 6 Induces Neuroblastoma Differentiation. Anticancer Res February 2018 38 (2) 647-654. ar.iiarjournals.org/content/38/2/647.abstract
Citation: A new target for neuroblastoma (2018, February 15) retrieved 19 August 2019 from https://medicalxpress.com/news/2018-02-neuroblastoma.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more